###begin article-title 0
###xml 75 79 <span type="species:ncbi:10090">Mice</span>
Abnormal Placental Development and Early Embryonic Lethality in EpCAM-Null Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: KN SM MCU. Performed the experiments: KN JZ MBH JCH LT. Analyzed the data: KN JZ MIM LT SM MCU. Contributed reagents/materials/analysis tools: MIM. Wrote the paper: KN MCU.
###end p 1
###begin p 2
Current address: Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 154 162 154 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
EpCAM (CD326) is encoded by the tacstd1 gene and expressed by a variety of normal and malignant epithelial cells and some leukocytes. Results of previous in vitro experiments suggested that EpCAM is an intercellular adhesion molecule. EpCAM has been extensively studied as a potential tumor marker and immunotherapy target, and more recent studies suggest that EpCAM expression may be characteristic of cancer stem cells.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 258 265 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 640 648 634 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in utero</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
To gain insights into EpCAM function in vivo, we generated EpCAM -/- mice utilizing an embryonic stem cell line with a tacstd1 allele that had been disrupted. Gene trapping resulted in a protein comprised of the N-terminus of EpCAM encoded by 2 exons of the tacstd1 gene fused in frame to betageo. EpCAM +/- mice were viable and fertile and exhibited no obvious abnormalities. Examination of EpCAM +/- embryos revealed that betageo was expressed in several epithelial structures including developing ears (otocysts), eyes, branchial arches, gut, apical ectodermal ridges, lungs, pancreas, hair follicles and others. All EpCAM -/- mice died in utero by E12.5, and were small, developmentally delayed, and displayed prominent placental abnormalities. In developing placentas, EpCAM was expressed throughout the labyrinthine layer and by spongiotrophoblasts as well. Placentas of EpCAM -/- embryos were compact, with thin labyrinthine layers lacking prominent vascularity. Parietal trophoblast giant cells were also dramatically reduced in EpCAM -/- placentas.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 226 230 <span type="species:ncbi:10090">mice</span>
EpCAM was required for differentiation or survival of parietal trophoblast giant cells, normal development of the placental labyrinth and establishment of a competent maternal-fetal circulation. The findings in EpCAM-reporter mice suggest involvement of this molecule in development of vital organs including the gut, kidneys, pancreas, lungs, eyes, and limbs.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 334 337 334 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Edwards1">[1]</xref>
###xml 338 341 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Ross1">[3]</xref>
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Bergsagel1">[4]</xref>
###xml 488 491 488 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Borkowski1">[5]</xref>
###xml 492 495 492 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Trzpis1">[7]</xref>
###xml 610 613 610 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Litvinov1">[8]</xref>
###xml 858 861 858 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Litvinov1">[8]</xref>
###xml 863 866 863 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Winter1">[9]</xref>
###xml 920 927 920 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1129 1133 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Balzar1">[10]</xref>
###xml 1135 1139 1135 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Ladwein1">[11]</xref>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 481 487 <span type="species:ncbi:9606">humans</span>
Epithelial cell adhesion molecule, EpCAM (CD326), (also termed EGP-2, Egp314, Ep-CAM, GA733-2, gp40, Ly74, panepithelial glycoprotein 314, TROP1, and tumor associated calcium transducer-1 (TACSTD1)), is a putative adhesion molecule. EpCAM was initially described as a cell surface protein that was selectively expressed by epithelial [1]-[3] and some myeloid cancers [4], but it is also expressed in a variety of normal epithelia including skin, thymus, and gut, in adult mice and humans [5]-[7]. Fibroblasts (L cells) that were transiently transfected with cDNA encoding EpCAM formed aggregates in suspension [8], suggesting that EpCAM functioned as a homophilic adhesion molecule. A subsequent study in which L cells were transfected with cDNAs encoding E-cadherin alone or E-cadherin and EpCAM suggested that EpCAM attenuated E-cadherin-mediated adhesion [8], [9]. Localization of EpCAM on polarized epithelial cells in situ indicated that the protein accumulated predominantly at intercellular basolateral interfaces that were in close apposition, but that it was excluded from desmosomes and perhaps tight junctions as well [10], [11].
###end p 10
###begin p 11
###xml 127 131 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Ladwein1">[11]</xref>
###xml 132 136 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Schmidt1">[13]</xref>
###xml 362 366 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Hemler1">[14]</xref>
###xml 494 498 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Maetzel1">[15]</xref>
###xml 582 586 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Dalerba1">[16]</xref>
###xml 617 621 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Yamashita1">[17]</xref>
###xml 623 627 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Yamashita2">[18]</xref>
###xml 813 817 810 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Yamashita2">[18]</xref>
###xml 1008 1012 1005 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Dalerba1">[16]</xref>
###xml 1014 1018 1011 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Yamashita2">[18]</xref>
###xml 652 657 <span type="species:ncbi:9606">human</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
Enrichment of EpCAM in tetraspanin enriched microdomains (TEMs) that contain beta1-integrins, CD44v, claudins and tetraspanins [11]-[13] is also consistent with the concept that EpCAM is involved in intercellular adhesion, but TEM-associated proteins have also been implicated in cell signaling and more complex processes including cell migration and metastasis [14]. Indeed, Maetzel et al recently described proteolytic fragments of EpCAM that participated in nuclear signaling in tumor cells [15]. It has also been reported that EpCAM was expressed by stem cells in colon cancers [16] and hepatocellular carcinomas [17], [18]. Studies conducted with human hepatocellular carcinoma cell lines suggested that EpCAM expression distinguished cells with stem-like properties from cells that were more differentiated [18]. In addition, selective knockdown of EpCAM in hepatocellular carcinoma stem cells attenuated their ability to form tumors in immunocompromised mice and, even more strikingly, to metastasize [16], [18]. The extent to which these latter findings might relate to modulation of intercellular adhesion is uncertain.
###end p 11
###begin p 12
###xml 144 147 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Borkowski1">[5]</xref>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Nagao1">[19]</xref>
###xml 365 372 365 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 512 519 512 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
We became interested in EpCAM after determining that, among dendritic cells, EpCAM was selectively expressed by epidermal Langerhans cells (LC) [5], [19], a distinctive resident skin leukocyte subpopulation with some epithelial characteristics. Because EpCAM function is incompletely characterized, and the functional activities of dendritic cells are best studied in vivo, we sought to explore the function of this molecule in EpCAM-deficient mice. We identified an embryonic stem (ES) cell line with an EpCAM (tacstd1) mutation created by gene trapping, and used it to generate EpCAM-knockout mice which we then characterized. EpCAM -/- mice exhibited early embryonic lethality with markedly abnormal placental development. Although many mechanistic aspects of EpCAM function remain to be elucidated, these results indicate that this protein is critical for normal placental development and plays one or more non-redundant roles in normal epithelial physiology.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
###xml 30 34 <span type="species:ncbi:10090">Mice</span>
Generation of EpCAM-Deficient Mice
###end title 14
###begin p 15
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Stryke1">[20]</xref>
###xml 566 570 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Stryke1">[20]</xref>
###xml 614 618 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Townley1">[21]</xref>
###xml 707 714 701 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 849 856 843 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 1101 1105 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Bonin1">[22]</xref>
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
###xml 1081 1086 <span type="species:ncbi:10090">Mouse</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
###xml 1364 1368 <span type="species:ncbi:10090">mice</span>
A mouse ES cell line containing an inserted gene trapping construct in tacstd1 (RST556, strain 129P2), the gene encoding EpCAM, was developed by BayGenomics (San Francisco, CA), a consortium of research groups supported by the National Heart, Lung and Blood Institute [20]. The gene-trap vector used (pGT0, 1, 2tm-pfs) contained a splice-acceptor sequence, en-2, upstream of a transmembrane domain that is fused in frame with the reporter gene/selectable marker betageo (itself a fusion protein with beta-galactosidase and neomycin phosphotransferase II activities) [20]. Using 5' rapid amplification of cDNA ends [21], we verified that the insertional mutation in RST556 was located in the third intron of tacstd1. This mutation resulted in the production of an in frame fusion transcript consisting of exons 1 (untranslated region), 2, and 3 from tacstd1, a CD2-derived transmembrane domain, and betageo. ES cells were microinjected into C57BL/6 recipient blastocysts to generate chimeras that transmitted the mutated allele to progeny in the Center for Cancer Research Knockout Mouse Core Facility [22]. EpCAM +/- mice were then inter-crossed to obtain homozygous deficient animals. For determination of embryonic ages, noon on the day of the post-coital plug was taken to be E0.5. Wild type and heterozygous littermates were used as controls as indicated. All mice were bred and housed in a pathogen-free environment and used in experiments in accordance with institutional guidelines at the Center for Cancer Research, National Cancer Institute, National Institutes of Health. All experimental procedures conducted in this study were approved by the Animal Care and Use Committee, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
###end p 15
###begin title 16
Genotyping
###end title 16
###begin p 17
###xml 48 78 48 78 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTCCAAACGTGAGTAAATCAATC-3&#8242;</named-content>
###xml 112 140 112 140 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGAAAGGCGATGACAGTAACG-3&#8242;</named-content>
###xml 203 230 203 230 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CACTCCAACCTCCGCAAACT-3&#8242;</named-content>
###xml 512 549 509 546 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCACTGGCCGTCGTTTTACAACGTCGTGA- 3&#8242;</named-content>
###xml 575 611 569 605 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGTGAGCGAGTAACAACCCGTCGGATTCT-3&#8242;</named-content>
The following primers were used for genotyping: 5'-GCTCCAAACGTGAGTAAATCAATC-3' (EpCAM wild-type forward; WT 1), 5'-TGGAAAGGCGATGACAGTAACG-3' (EpCAM wild-type reverse; WT 2) for the wild-type allele, and 5'- CACTCCAACCTCCGCAAACT-3' (EpCAM mutant reverse; KO 1) in conjunction with the wild-type forward primer to detect the mutant allele. Because the primer pair that amplified betageo gave identical results but yielded more robust signals, the following primers were subsequently used to detect mutant alleles: 5'-TTCACTGGCCGTCGTTTTACAACGTCGTGA- 3' (betageo forward; KO 2), 5'-ATGTGAGCGAGTAACAACCCGTCGGATTCT-3' (betageo reverse; KO 3).
###end p 17
###begin title 18
beta-galactosidase Staining
###end title 18
###begin p 19
To ascertain EpCAM expression patterns, whole embryos were stained with a beta-galactosidase staining kit (Invitrogen) in accordance with the manufacturer's instructions. In brief, embryos were fixed in 2% glutaldehyde/2% paraformaldehyde for 15-60 min depending on the age of embryo, stained overnight with X-gal solution, and post-fixed with 4% PFA.
###end p 19
###begin title 20
Laser Capture Microdissection
###end title 20
###begin p 21
Embryonic tissue was acquired from formalin-fixed, paraffin-embedded tissue sections via laser capture microdissection (LCM) using the Veritas microdissection system (MDS Analytical Technologies) in the Center for Cancer Research Laser Capture Microdissection core facility. Genomic DNA was purified with QIAamp DNA micro kits (Qiagen) and genotypes were determined by PCR.
###end p 21
###begin title 22
Immunofluorescence Microscopy
###end title 22
###begin p 23
###xml 371 375 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Hwang1">[23]</xref>
###xml 422 426 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-PeraltaSoler1">[24]</xref>
###xml 708 712 <span type="species:ncbi:9925">goat</span>
###xml 716 722 <span type="species:ncbi:9793">donkey</span>
###xml 744 749 <span type="species:ncbi:10090">mouse</span>
###xml 943 947 <span type="species:ncbi:9925">goat</span>
###xml 954 960 <span type="species:ncbi:9986">rabbit</span>
###xml 970 973 <span type="species:ncbi:10116">rat</span>
The following antibodies were used for immunofluorescence microscopy: anti-EpCAM (10 microg/ml; clone G8.8, Developmental Hybridoma Bank, University of Iowa), anti-E-cadherin (10 microg/ml; ECCD-2, Invitrogen), anti-P-cadherin (10 microg/ml; PCD-1, Invitrogen), and anti-PL-1 (10 microg/ml; Santa Cruz Biotech). The polyclonal anti-Dlx3 antibody was described previously [23]. Antigen retrieval was performed as described [24]. Briefly, formalin-fixed, paraffin-embedded tissue sections were deparaffinized and subjected to 5x2 min cycles of microwave treatment in citrate buffer (pH 6) and allowed to cool to room temperature. Antigen-retrieved or frozen sections were blocked with 3% milk (Bio-Rad) and 5% goat or donkey serum in addition to mouse IgG (10 microg/ml) for 1 hr at room temperature. Primary antibodies were incubated overnight at 4degreesC, sections were washed, and bound antibodies were detected with AlexaFluor-labeled anti-goat, anti-rabbit, or anti-rat secondary antibodies (5 microg/ml; Invitrogen). Stained sections were mounted in Prolong Gold with DAPI (Invitrogen) and analyzed. Immunofluorescence images were collected and visualized with an AxioImager A1 imunofluorescence microscope (Zeiss) and Axiovision software version 4.6 (Zeiss). Intensity levels of digital images in experimental and control specimens were adjusted proportionally and in the linear range either in Axiovison or Photoshop CS2 (Adobe).
###end p 23
###begin title 24
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
In situ hybridization
###end title 24
###begin p 25
###xml 212 219 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Pizard1">[25]</xref>
A 950 bp EpCAM cDNA fragment was inserted into BamHI-EcoRI sites of pcDNA3 (Invitrogen). Antisense Digoxigenin-labeled RNA probes were synthesized with BamHI-linearized vector and Sp6 RNA polymerase. Whole mount in situ hybridization was carried out using an established protocol [25] with a short proteinase K treatment (2 microg/ml proteinase K for 5 min).
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 14 18 <span type="species:ncbi:10090">Mice</span>
Generation of Mice with a Mutated tacstd1 Allele
###end title 27
###begin p 28
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Generation of knockout mice by gene trapping involves random insertion of a construct that includes an splice acceptor that efficiently "traps" one or more upstream exons by incorporating them into a fusion protein encoded by a cDNA immediately downstream of the splice acceptor site. In the vector used in the present study, the cDNA downstream of the splice acceptor site encodes a portion of CD2 (inclusive of the transmembrane domain) in frame with a fusion protein that retains beta-galactosidase and neomycin phosphotransferase activities (betageo). Because expression of the fusion protein that results from gene trapping is expected to occur only in cells in which the targeted locus is being actively transcribed, the pattern and intensity of expression of betageo can be studied as a surrogate marker for expression of the protein encoded by the targeted gene.
###end p 28
###begin p 29
###xml 211 218 211 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 350 356 350 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g001">Fig. 1</xref>
###xml 567 588 567 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">Mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
After searching the Baygenomics database (see International gene trap consortium, ), we identified four ES cell lines that were predicted to include the gene trapping vector inserted in the gene encoding EpCAM (tacstd1). For this study, we utilized ES cell line RST556 that contained the trapping construct inserted into the third intron of tacstd1 (Fig. 1). A chimeric male founder mouse was generated and crossed to normal C57BL/6 mice to generate heterozygous mice containing one copy of the mutated EpCAM allele. Mice were genotyped using PCR as described in the Materials and Methods. EpCAM +/- mice were viable, healthy, grossly indistinguishable from their wildtype littermate counterparts, and were fertile.
###end p 29
###begin title 30
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tacstd1</italic>
###xml 43 49 <span type="species:ncbi:10090">murine</span>
Disruption of the tacstd1gene that encodes murine EpCAM.
###end title 30
###begin p 31
The schematic indicates the site of insertion of the gene trapping vector as well as the structure of the mRNA that encodes the EpCAM/betageo fusion protein. Locations of primers used for genotyping are also depicted.
###end p 31
###begin title 32
Expression of EpCAM in Multiple Organs during Development
###end title 32
###begin p 33
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Sherwood1">[26]</xref>
###xml 369 379 369 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g002">Fig. 2A, B</xref>
###xml 538 552 538 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g002">Fig. 2E&#8211;I, F&#8211;J</xref>
###xml 753 763 753 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g002">Fig. 2C, D</xref>
###xml 876 885 876 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g002">Fig. 2K&#8211;N</xref>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Stephan1">[27]</xref>
###xml 1133 1142 1133 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g002">Fig. 2K&#8211;T</xref>
###xml 1144 1151 1144 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008543-t001">Table 1</xref>
###xml 939 943 <span type="species:ncbi:10116">rats</span>
Evaluation of EpCAM expression using LacZ staining at E8.5 revealed a pattern that was predominantly endodermal (data not shown), consistent with recent reports that indicated that EpCAM can be used as a marker to enrich endodermal cells from early embryos [26]. At E9.5, EpCAM expression was most prominent in the facial primordia, gut, branchial arches, and otocyst (Fig. 2A, B). Corresponding transverse sections revealed concordant expression of EpCAM as demonstrated by LacZ or immunofluorescence staining using anti-EpCAM antibody (Fig. 2E-I, F-J). At E11.5 and earlier, the periocular region, the apical ectodermal ridge precursors (ventral limb ectoderm) and mature ridge, and inter-somitic regions in the posterior trunk/tail stained positive (Fig. 2C, D). Particularly prominent expression was evident in developing hair follicles in whole mounts prepared at E14.5 (Fig. 2K-N). In analogy to what has previously been reported in rats [27], EpCAM expression was readily detected in some epithelial components of a variety of organs including hair follicles, the nasal plexus, lungs, kidneys, and pancreas examined at E14.5 (Fig. 2K-T, Table 1).
###end p 33
###begin title 34
Expression of EpCAM during embryonic development.
###end title 34
###begin p 35
###xml 464 466 464 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 398 401 <span type="species:ncbi:10116">rat</span>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
(A-D) Whole mount LacZ staining (A&C, in blue) and in situ hybridization (B&D, in purple) of E9.5 (A&B) and E11.5 (C&D) embryos. EpCAM expression in the apical ectodermal ridges (arrowheads), around the eyes (arrows) and inter-somitic regions (asterisks) is highlighted in C and D. Corresponding transverse sections with LacZ and light H&E staining (E, G, I), and immunofluorescence staining using rat anti-mouse EpCAM mAb (F, H, J, in green). OC = otocyst, BC = 1st branchial cleft, Ph = pharynx, HD = hindgut diverticulum. (K-T) EpCAM expression in epithelia in a variety of organs at E14.5. K, M, O, Q, and S show LacZ and N, P, R, T show immunofluorescence staining. Primordial hair follicles are prominently stained in the E14.5 embryo as determined by LacZ staining (K&M), in situ hybridization (L), and immunofluorescence (N). M to T shows EpCAM expression in skin (M&N), nasal plexus (O&P), lungs (Q&R), and kidneys (S&T). Bars = 100 microm. HF = hair follicle, HP = hair placode, OE = olfactory epithelium, BT = bronchiolar tubules, LS = lung saccules, UB = ureteric bud branches.
###end p 35
###begin title 36
EpCAM expression patterns in various organs during embryonic development.
###end title 36
###begin title 37
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
Embryonic Lethality in EpCAM-Deficient Mice
###end title 37
###begin p 38
###xml 156 163 156 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008543-t002">Table 2</xref>
###xml 365 372 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008543-t003">Table 3</xref>
###xml 594 600 592 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g003">Fig. 3</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
EpCAM +/- mice were intercrossed to generate homozygous deficient animals. No EpCAM -/- pups were identified in >24 litters born to >10 breeding pairs (see Table 2). Examination of embryos of various gestational ages revealed that EpCAM -/- embryos appeared to develop normally up to E8.5, after which development arrested, and became nonviable during E10.5-E11.5 (Table 3). EpCAM-/- embryos with gestational ages >/=E12.5 were not identified. At E9.5, EpCAM -/- embryos were significantly smaller than EpCAM-sufficient siblings and sometimes exhibited delayed, incomplete neural tube closure (Fig. 3). Localization of betageo in whole mounts and sagittal sections of E9.5 EpCAM-deficient embryos revealed intense staining of otocysts, branchial arches and gut.
###end p 38
###begin title 39
Developmental delay in EpCAM-deficient embryos.
###end title 39
###begin p 40
(A) Embryonic development in wild type, haplosufficient and EpCAM-deficient littermate embryos (E9.5). Arrows indicate open neural tube. Sagittal sections show EpCAM (betageo) expression in gut endoderm in EpCAM +/- and EpCAM -/- embryos (arrowheads). The embryos depicted were littermates and photos of whole mounts were taken at identical magnifications. (B) Genotypes of embryos depicted in (A).
###end p 40
###begin title 41
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Distribution of genotypes in viable pups resulting from matings of EpCAM +/- mice.
###end title 41
###begin title 42
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Time course of lethality in EpCAM -/- mice.
###end title 42
###begin p 43
most remaining live embryos developmentally arrested at E10.5-10.5.
###end p 43
###begin p 44
number of litters examined in parentheses.
###end p 44
###begin title 45
EpCAM Expression in Developing Placenta
###end title 45
###begin p 46
###xml 448 455 448 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g004">Fig. 4A</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g005">5C</xref>
Although EpCAM was widely expressed in developing embryos, the early embryonic lethality that we detected suggested the possibility of an extra-embryonic cause. To address this possibility, we examined placentas for evidence of EpCAM expression. Localization of EpCAM in frozen tissue from E8.5 and E9.5 placentas using immunofluorescence microscopy revealed expression in the allantois, the labyrinthine layer, and in spongiotrophoblasts as well (Fig. 4A & 5C). The highest levels of expression were detected in the labyrinth. Interestingly, vascular structures in the maternal decidua also stained strongly for EpCAM.
###end p 46
###begin title 47
Defective placental development in the absence of EpCAM.
###end title 47
###begin p 48
(A) EpCAM expression in wild type C57BL/6 placentas at E 9.5 as shown by immunofluorescence staining (left). Bar = 200 microm. Right panel shows a schematic of E9.5 placenta. La = labyrinth, Sp = spongiotrophoblasts, TGC = parietal trophoblast giant cells, V = vasculature. (B) Morphology in H&E stained sections of EpCAM +/- and -/- placentas. Bars = 50 and 20 microm. Panels on the right represent high power view of insets in the left panels. Arrow in B highlights intravascular microthrombus.
###end p 48
###begin title 49
Diminished parietal trophoblast giant cell population in EpCAM -/- placentas.
###end title 49
###begin p 50
(A) Sections of E9.5 placenta double-stained with anti-Dlx3 antibody and anti-PL-1 antibody after antigen retrieval. (B) Anti-PL-1 staining of a section that contained two embryos (EpCAM -/-, upper embryo; EpCAM +/-, lower embryo) in one E9.5 uterine decidual swelling. (C) EpCAM and DAPI staining of a frozen section of an E9.5 wild type placenta. Bars = 50 (A), 200 (B), and 20 microm (C).
###end p 50
###begin p 51
###xml 95 103 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in utero</italic>
###xml 422 429 422 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g004">Fig. 4B</xref>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
To preserve spatial relationships and obtain optimal placental morphology, we embedded embryos in utero and prepared sections from formalin-fixed, paraffin-embedded tissues. Placentas were subsequently genotyped using embryo-derived genomic DNA that was obtained from adjacent sections using laser-capture microdissection. E8.5 EpCAM -/- extra-embryonic tissues showed no obvious abnormality (data not shown). As shown in Fig. 4B, whereas well-developed labyrinthine layers with obvious villi were present in E9.5 EpCAM +/- placentas, placentas from EpCAM -/- mice were small, the labyrinthine layer was thin and villous formation was limited. EpCAM -/- placentas were also notable for markedly decreased frequencies of parietal trophoblast giant cells. In addition, micro-thrombi were observed in surrounding capillaries adjacent to the chorionic plate in some EpCAM -/- placentas, suggesting impaired fluid flow or hypercoagulability.
###end p 51
###begin title 52
EpCAM -/- Placentas Contain Decreased Numbers of Parietal Trophoblast Giant Cells
###end title 52
###begin p 53
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Morasso1">[28]</xref>
###xml 420 427 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g005">Fig. 5A</xref>
###xml 592 599 592 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g005">Fig. 5B</xref>
###xml 686 693 686 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g004">Fig. 4B</xref>
###xml 785 792 785 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g005">Fig. 5A</xref>
###xml 1152 1159 1152 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g005">Fig. 5C</xref>
To better characterize cellular constituents of EpCAM -/- placentas, tissue sections of E9.5 placentas were stained for placental lactogen-1 (PL-1) and Dlx3, markers that identify parietal trophoblast giant cells and the labyrinth, respectively [28]. PL-1 positive parietal trophoblast giant cells were normally represented in EpCAM +/- placentas, but they were dramatically reduced in number in EpCAM-deficient tissue (Fig. 5A). The differences were particularly striking in an example of fraternal twin embryos, one EpCAM -/- and the other EpCAM +/-, in a single uterine decidual swelling (Fig. 5B). Consistent with the morphology observed in hematoxylin- and eosin-stained sections (Fig. 4B), the Dlx3-expressing labyrinth layer thickness was markedly reduced in EpCAM -/- embryos (Fig. 5A). Dlx3 was clearly expressed, however, and the levels of expression in EpCAM -/- tissue may exceed that present in normal placentas. To directly address the issue of EpCAM expression by parietal trophoblast giant cells, we stained frozen sections with anti-EpCAM antibodies and DAPI. Interestingly, EpCAM was not detected on parietal trophoblast giant cells (Fig. 5C).
###end p 53
###begin title 54
Distribution of EpCAM and Cadherins in Developing Placenta
###end title 54
###begin p 55
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Balzar1">[10]</xref>
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Litvinov2">[29]</xref>
###xml 358 365 358 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g006">Fig. 6A</xref>
Because previous studies suggested that EpCAM might modulate cadherin function [10], [29], we characterized E9.5 placentas for expression of EpCAM, E-cadherin and P-cadherin. EpCAM was co-expressed with E-cadherin throughout the labyrinth, with the highest levels of EpCAM expression occurring on cells in closest proximity to the embryonic chorionic plate (Fig. 6A). In striking contrast, expression of EpCAM was inversely correlated with P-cadherin expression, which was selectively expressed by spongiotrophoblasts. E-cadherin and P-cadherin were reciprocally expressed in the labyrinth, but appeared to be co-expressed in the spongiotrophoblast layer.
###end p 55
###begin title 56
Cadherin expression in EpCAM-sufficient and deficient placentas.
###end title 56
###begin p 57
(A) Frozen sections from E9.5 wild type placentas stained for EpCAM, E-, and P-cadherins (La = labyrinth). (B) Sections from formalin-fixed, paraffin-embedded tissues stained for E-cadherin and P-cadherin after antigen retrieval. Bars = 20 microm.
###end p 57
###begin p 58
###xml 335 342 335 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008543-g006">Fig. 6B</xref>
To determine if placental cadherin expression might be perturbed in the absence of EpCAM, we stained formalin-fixed, paraffin-embedded sections from EpCAM +/- and EpCAM -/- placentas for E- and P-cadherin after antigen retrieval. Although the labyrinth was clearly abnormal in EpCAM -/- placentas, E-cadherin was expressed throughout (Fig. 6B). P-cadherin distribution was not obviously different in EpCAM-deficient as compared with EpCAM-sufficient placentas.
###end p 58
###begin title 59
Relationships between EpCAM and Cadherin Expression in Other Tissues
###end title 59
###begin p 60
###xml 462 470 462 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008543.s001">Fig. S1A</xref>
###xml 580 588 580 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008543.s001">Fig. S1B</xref>
###xml 885 893 885 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008543.s001">Fig. S1C</xref>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
The co-expression of EpCAM and E-cadherin and the reciprocal expression that we observed with P-cadherin in placenta was striking. To determine if these relationships were maintained in EpCAM-expressing epithelia in other developing organs, we surveyed skin, gut and lung in E14.5 mice using immunofluorescence microscopy. We observed that E-cadherin and EpCAM were concordantly expressed in developing gut, and P-cadherin and EpCAM were reciprocally expressed (Fig. S1A). In developing lung, most (but not all) E-cadherin-expressing developing bronchi also expressed P-cadherin (Fig. S1B). Those that did not express P-cadherin stained for EpCAM, and there was no overlap between EpCAM and P-cadherin expression. In developing hair follicles, EpCAM and E-cadherin were concordantly expressed by superficial epithelial cells, while P-cadherin staining was most intense on basal cells (Fig. S1C).
###end p 60
###begin title 61
Discussion
###end title 61
###begin p 62
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Stryke1">[20]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Skarnes1">[30]</xref>
###xml 332 336 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Stephan1">[27]</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 320 323 <span type="species:ncbi:10116">rat</span>
We generated EpCAM-deficient mice to gain additional insights into EpCAM function in vivo. We utilized a pre-existing ES stem cell clone [20], [30] with a targeted allele producing a fusion protein that contained a short N-terminal portion of EpCAM in addition to betageo. Consistent with results previously reported in rat embryos [27], we determined that EpCAM was expressed in a variety of epithelial structures, including apical ectodermal ridges, signaling centers that are essential for limb bud outgrowth. In all epithelial tissues examined, EpCAM and E-cadherin were expressed by the same cells, whereas EpCAM was reciprocally expressed with P-cadherin.
###end p 62
###begin p 63
###xml 571 578 571 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
No viable EpCAM -/- pups were obtained. Examination of embryos obtained after timed heterozygote matings revealed that -/- embryos implanted, and that control and EpCAM-deficient embryos could not be distinguished on or before E8.5. By E9.5, however, EpCAM knockout embryos were smaller than EpCAM sufficient embryos, neural tube closure was often delayed, and all EpCAM knockout embryos became nonviable before E12.5. Our observation of prominent EpCAM expression in the early placenta prompted us to look for extraembryonic abnormalities. Studies of implantation sites in situ revealed that placentas associated with EpCAM -/- embryos were small and thin, the latter characteristic reflecting more compact labyrinthine layers that did not exhibit prominent villous formation or vascularity. Numbers of parietal trophoblast giant cells were also strikingly diminished in EpCAM-deficient placentas. Localization of EpCAM in E8.5 and E9.5 placentas revealed that the protein was highly expressed by trophoblasts in the labyrinthine layer and also by spongiotrophoblasts. EpCAM was not detected on parietal trophoblast giant cells, suggesting the possibility of a nonautonomous effect on giant cell number.
###end p 63
###begin p 64
###xml 94 97 94 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Winter1">[9]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Litvinov2">[29]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Larue1">[31]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Riethmacher1">[32]</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Radice1">[33]</xref>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
In light of previous studies implicating EpCAM as a modulator of E-cadherin-mediated adhesion [9], [29], it is interesting to compare the phenotypes of EpCAM- and cadherin-deficient mice. E-cadherin-deficient embryos do not form trophectoderm or blastocysts and do not implant [31], [32]. Although both E-cadherin and EpCAM are widely expressed in early embryos and in developing epithelia, post-implantation placental abnormalities were the most striking changes identified in the setting of EpCAM deficiency. P-cadherin is abdundant in placenta and is frequently expressed in developing and adult epithelia, but P-cadherin-deficient mice were viable, fertile, and they did not exhibit obvious epithelial abnormalities [33]. It has been suggested that the ability of E-cadherin to compensate for loss of P-cadherin in many tissues may explain the unexpectedly mild phenotype of P-cadherin-deficient mice. Clearly, EpCAM has one or more important functions that cannot be compensated by other proteins, including E-cadherin.
###end p 64
###begin p 65
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Simmons1">[34]</xref>
###xml 804 808 804 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Bany1">[35]</xref>
###xml 810 814 810 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Simmons2">[36]</xref>
###xml 961 966 961 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hand1</italic>
###xml 1077 1082 1077 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I-mfa</italic>
###xml 1100 1105 1100 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mash2</italic>
###xml 1311 1315 1311 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Kraut1">[37]</xref>
###xml 1317 1321 1317 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Riley1">[38]</xref>
###xml 1602 1606 1602 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Anderson1">[39]</xref>
###xml 1629 1633 1629 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Dalerba1">[16]</xref>
###xml 1635 1639 1635 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Yamashita1">[17]</xref>
###xml 1641 1645 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Dan1">[40]</xref>
The embryonic lethality of EpCAM deficiency may reflect an as yet uncharacterized global effect on epithelial cell physiology, or a requirement for EpCAM in the development or survival of a critical placental cell type. The diminished frequency of parietal trophoblast giant cells is among the most striking histologic abnormalities in EpCAM-deficient placentas. Parietal trophoblast giant cells are the first cells to differentiate from the trophoectoderm, but they may also derive from trophoblasts and spongiotrophoblasts via endoreplication [34]. Parietal trophoblast giant cells invade into the uterine wall, establishing a receptive environment for development of a functional maternal-fetal interface via elaboration of paracrine factors including VEGF, metalloproteinases, hormones and cytokines [35], [36]. Alternatively, the embryonic lethality seen in our study may be secondary to parietal trophoblast giant cell deficiency, since null mutations in Hand1 (a basic helix-loop-helix transcription factor that enhances parietal trophoblast giant cell development) and I-mfa (an inhibitor of Mash2, a basic helix-loop-helix protein that inhibits parietal trophoblast giant cell development) both lead to parietal trophoblast giant cell deficiency, arrested placental development and embryonic lethality [37], [38]. Because EpCAM-deficient placentas were smaller and the labyrinthine layers were thinner and less elaborate than in controls, impaired placental development in this setting may reflect a more global effect on epithelial cell physiology. EpCAM is expressed by embryonic stem cells [39] and cancer stem cells [16], [17], [40], and it is possible that EpCAM influences trophoblast stem cell behavior.
###end p 65
###begin p 66
###xml 84 91 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Sivagnanam1">[41]</xref>
###xml 1395 1399 1395 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008543-Slanchev1">[42]</xref>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 633 641 <span type="species:ncbi:9606">patients</span>
###xml 840 848 <span type="species:ncbi:9606">patients</span>
###xml 1093 1097 <span type="species:ncbi:10090">mice</span>
###xml 1102 1117 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1305 1314 <span type="species:ncbi:7955">zebrafish</span>
###xml 1462 1466 <span type="species:ncbi:10090">mice</span>
In future studies, it will be of interest to explore other potential roles of EpCAM in vivo. These studies will require generation of mice that carry EpCAM alleles that can be targeted in selected lineages and/or at selected times. The importance of elucidating EpCAM function in vivo is highlighted by recent studies that demonstrate that at least some cases of congenital tufting enteropathy, a rare, typically autosomal recessive syndrome that is characterized by intractable infantile diarrhea, result from mutations in the gene encoding EpCAM [41]. Intrauterine demise or abnormal fertility has not been reported in families of patients with congenital tufting enteropathy, but it may be significant that null mutations in the gene encoding EpCAM, or mutations that resulted in truncated EpCAM protein, have not yet been identified in patients. The mutations identified to date may be hypomorphs that result in identifiable abnormalities in some EpCAM-expressing epithelia (eg intestinal epithelia and perhaps ocular conjunctiva), but not others. The availability of conditional knockout mice and transgenic mice that express candidate hypomorphic EpCAM alleles will allow EpCAM function to be additionally explored in embryonic development, reproduction, and adult physiology. Recent experiments in zebrafish implicate EpCAM in epithelial morphogenesis during epiboly and skin development [42], suggesting that future studies of conditional EpCAM knockout mice will be informative.
###end p 66
###begin title 67
Supporting Information
###end title 67
###begin p 68
Co-expression of EpCAM and E-cadherin and reciprocal expression with P-cadherin in epithelia in developing non-placental tissues. EpCAM, E-cadherin and P-cadherin were stained in frozen sections from E14.5 embryos in the (A) gut, (B) lungs (BT = bronchiolar tubules, LS = lung saccules), (C) and hair follicles. EpCAM and E-cadherin expression is present in gut epithelium, and P-cadherin is expressed in muscular/serosal layers in (A). Bars = 100 microm (A&B), and 20 microm (C).
###end p 68
###begin p 69
(7.94 MB TIF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
The authors thank Susan Reid and Eileen Southern for handling and microinjection of embryonic stem cells.
###end p 71
###begin title 72
References
###end title 72
###begin article-title 73
###xml 109 114 <span type="species:ncbi:9606">human</span>
Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
###end article-title 73
###begin article-title 74
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.
###end article-title 74
###begin article-title 75
Isolation and characterization of a carcinoma-associated antigen.
###end article-title 75
###begin article-title 76
###xml 2 8 <span type="species:ncbi:10090">murine</span>
A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells.
###end article-title 76
###begin article-title 77
###xml 24 30 <span type="species:ncbi:10090">murine</span>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 97 103 <span type="species:ncbi:10090">murine</span>
Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells.
###end article-title 77
###begin article-title 78
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 22 27 <span type="species:ncbi:9606">human</span>
The murine homolog of human Ep-CAM, a homotypic adhesion molecule, is expressed by thymocytes and thymic epithelial cells.
###end article-title 78
###begin article-title 79
Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule.
###end article-title 79
###begin article-title 80
###xml 10 15 <span type="species:ncbi:9606">human</span>
Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.
###end article-title 80
###begin article-title 81
Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak.
###end article-title 81
###begin article-title 82
Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions.
###end article-title 82
###begin article-title 83
The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7.
###end article-title 83
###begin article-title 84
A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression.
###end article-title 84
###begin article-title 85
CD44 variant isoforms associate with tetraspanins and EpCAM.
###end article-title 85
###begin article-title 86
Tetraspanin functions and associated microdomains.
###end article-title 86
###begin article-title 87
Nuclear signalling by tumour-associated antigen EpCAM.
###end article-title 87
###begin article-title 88
###xml 31 36 <span type="species:ncbi:9606">human</span>
Phenotypic characterization of human colorectal cancer stem cells.
###end article-title 88
###begin article-title 89
Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
###end article-title 89
###begin article-title 90
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
###end article-title 90
###begin article-title 91
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions.
###end article-title 91
###begin article-title 92
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
BayGenomics: a resource of insertional mutations in mouse embryonic stem cells.
###end article-title 92
###begin article-title 93
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Rapid sequence analysis of gene trap integrations to generate a resource of insertional mutations in mice.
###end article-title 93
###begin article-title 94
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Isolation, microinjection, and transfer of mouse blastocysts.
###end article-title 94
###begin article-title 95
Dlx3 is a crucial regulator of hair follicle differentiation and cycling.
###end article-title 95
###begin article-title 96
Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors.
###end article-title 96
###begin article-title 97
Whole-mount in situ hybridization and detection of RNAs in vertebrate embryos and isolated organs.
###end article-title 97
###begin article-title 98
Prospective isolation and global gene expression analysis of definitive and visceral endoderm.
###end article-title 98
###begin article-title 99
Selective cloning of cell surface proteins involved in organ development: epithelial glycoprotein is involved in normal epithelial differentiation.
###end article-title 99
###begin article-title 100
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Placental failure in mice lacking the homeobox gene Dlx3.
###end article-title 100
###begin article-title 101
Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins.
###end article-title 101
###begin article-title 102
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Capturing genes encoding membrane and secreted proteins important for mouse development.
###end article-title 102
###begin article-title 103
E-cadherin null mutant embryos fail to form a trophectoderm epithelium.
###end article-title 103
###begin article-title 104
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development.
###end article-title 104
###begin article-title 105
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Precocious mammary gland development in P-cadherin-deficient mice.
###end article-title 105
###begin article-title 106
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Diverse subtypes and developmental origins of trophoblast giant cells in the mouse placenta.
###end article-title 106
###begin article-title 107
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Post-implantation mouse conceptuses produce paracrine signals that regulate the uterine endometrium undergoing decidualization.
###end article-title 107
###begin article-title 108
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Determinants of trophoblast lineage and cell subtype specification in the mouse placenta.
###end article-title 108
###begin article-title 109
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Requirement of the mouse I-mfa gene for placental development and skeletal patterning.
###end article-title 109
###begin article-title 110
The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis.
###end article-title 110
###begin article-title 111
Expression of the homophilic adhesion molecule, Ep-CAM, in the mammalian germ line.
###end article-title 111
###begin article-title 112
###xml 47 52 <span type="species:ncbi:9606">human</span>
Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages.
###end article-title 112
###begin article-title 113
Identification of EpCAM as the gene for congenital tufting enteropathy.
###end article-title 113
###begin article-title 114
###xml 106 115 <span type="species:ncbi:7955">zebrafish</span>
The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development.
###end article-title 114
###begin p 115
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 115
###begin p 116
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: These studies were supported the Intramural Program of the NIH, specifically the Center for Cancer Research of the NCI and the Intramural Program of NIAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 116

